These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3753512)

  • 1. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
    Waring RH; Mitchell SC; O'Gorman J; Fraser M
    Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphic sulphoxidation of carbocisteine.
    Meese CO; Hofmann U; Eichelbaum M
    Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetically determined impaired drug sulphoxidation.
    Waring RH; Mitchell SC; Idle JR; Smith RL
    Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
    [No Abstract]   [Full Text] [Related]  

  • 5. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
    Panagopoulos P; Mitchell SC; Steventon GB
    Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deficiency of sulfoxidation of S-carboxymethyl-L-cysteine.
    Mitchell SC; Waring RH
    Pharmacol Ther; 1989; 43(2):237-49. PubMed ID: 2675135
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
    Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.
    Karim EF; Millership JS; Temple DJ; Woolfson AD
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):253-6. PubMed ID: 3243319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbocisteine sulphoxidation phenotype.
    Waring RH; Mitchell SC
    Lancet; 1990 Jun; 335(8704):1527. PubMed ID: 1972452
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population.
    Haley CS; Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Xenobiotica; 1985 May; 15(5):445-50. PubMed ID: 4036168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.
    Steventon GB; Mitchell SC
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1213-21. PubMed ID: 19653802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the sulfur-oxygenation of cysteine and S-carboxymethyl-l-cysteine in human hepatic cytosol and the rôle of cysteine dioxygenase.
    Steventon GB; Khan S; Mitchell SC
    J Pharm Pharmacol; 2018 Aug; 70(8):1069-1077. PubMed ID: 29882598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
    Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
    J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor sulphoxidation in primary biliary cirrhosis.
    Olomu A; Clements D; Waring R; Elias E
    Lancet; 1985 Jun; 1(8444):1504. PubMed ID: 2861427
    [No Abstract]   [Full Text] [Related]  

  • 15. Variation in human metabolism of S-carboxymethylcysteine.
    Waring RH
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):49-52. PubMed ID: 7389752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphoxidation of S-carboxymethyl-L-cysteine in the rhesus monkey (Macaca mulatta), cynomologus monkey (Macaca fascicularis), African green monkey (Cercopithecus aethiops) and the marmoset (Callithrix jacchus).
    Mitchell SC; Waring RH; Wilson VL; Idle JR; Autrup H; Harris CC; Ritchie JC; Crothers MJ; Sieber SM
    Comp Biochem Physiol B; 1986; 84(2):143-4. PubMed ID: 3089678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC-analysis of S-carboxymethylcysteine and its sulphoxide metabolites.
    Brockmöller J; Simane ZJ; Roots I
    Drug Metabol Drug Interact; 1988; 6(3-4):447-56. PubMed ID: 3271650
    [No Abstract]   [Full Text] [Related]  

  • 18. Does sulphoxidation state predict gold toxicity in rheumatoid arthritis?
    Madhok R; Capell HA; Waring R
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):483. PubMed ID: 3103737
    [No Abstract]   [Full Text] [Related]  

  • 19. The S-oxidation of S-carboxymethyl-L-cysteine in hepatic cytosolic fractions from BTBR and phenylketonuria enu1 and enu2 mice.
    Steventon GB; Mitchell SC
    Xenobiotica; 2019 Apr; 49(4):495-502. PubMed ID: 29648495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of metabolites of S-carboxymethyl-L-cysteine and S-methyl-L-cysteine and of some isotopically labelled (2H, 13C) analogues.
    Meese CO; Specht D; Hofmann U
    Arch Pharm (Weinheim); 1990 Dec; 323(12):957-65. PubMed ID: 2096798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.